Premarket movers: Magnificent Seven stocks are all higher (Amazon +0.1%, Tesla +1%, Apple +1.4%, Meta +0.4%, Nvidia +0.2%, Microsoft flat, Alphabet +0.2%). Celcuity (CELC) is up 46% after the biotechnology company said it has successfully recruited enough breast-cancer patients with the PIK3CA mutation to complete Phase 3 clinical trials of a novel treatment that incorporates the drug gedatolisib. Cooper Cos. (COO) shares climb 4% after the Wall Street Journal reported that activist investor Jana Partners has built a stake in the medical device company and plans to push for strategic alternatives. Exelixis (EXEL) drops 11% after the drugmaker gave data from two separate late-stage cancer trials. Hologic Inc. (HOLX) climbs 5% as Blackstone Inc. and TPG Inc. are in advanced negotiations to acquire the company in a deal that could value the medical device maker at more than 17 billion including debt. A transaction could be announced in the coming days, according to people familiar with the matter. Olema Pharmaceuticals (OLMA) tumbles 28% after the drug developer gave data from an early-mid stage breast cancer trial, that Oppenheimer says is overshadowed by disappointing results from peer developer, Roche. Sable Offshore Corp. (SOC) rises 15% after US Secretary of Energy Chris Wright made an X post Friday night supporting the company’s effort to restart one of its California oil projects that is awaiting state approval.(zerohedge)